This session highlights how pharma can move beyond retrospective adherence measures and start using predictive insights to better support patients. By combining the COM-B behavioral model with AI-driven tools, the discussion explores new ways to identify barriers such as motivation, confidence, and social support — and how these insights can be applied to create more personalized, patient-first strategies.